Johnson & Johnson’s one-shot Covid-19 vaccine appears to be safe and effective after trials.
The company’s submitted documents say the vaccine was 66 per cent effective in preventing Covid-19 in a global trial. It also found that the shot helped prevent asymptomatic infections. It is amongst the first vaccines to require only one dose to fully inoculate.
A panel of independent experts will meet on Friday, Feb. 26 to decide whether to recommend the drug for emergency use to the U.S Food and Drug Administration.
Skedline.com reporter Nick Barnsdale has the story.